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ACTIVE CANCERS MORE TREATABLE SAYS 
LECTURING PHYSICIAN
MISSOULA--
Fast-growing, widely-disseminated cancers respond better to cancer 
chemotherapy than do large, slow-growing tumors, said Dr. John M. Trauchst, 
a physician specializing in cancer treatment.
Dr. Trauchst gave the first in the lecture series ’Recent Advances in 
Clinical Medicine." Held each Thursday at 11 a.m. during winter quarter at 
the University of Montana, the lectures are free and open to the public.
They are held in Room 109 of the Chemistry-Pharmacy Building on the UM campus 
and are sponsored jointly by the School of Pharmacy and Allied Health Sciences 
and the Center for Continuing Education.
In explaining the strategies of cancer treatment, Dr. Trauchst said that 
many anti-cancer drugs work by selectively killing cells that rapidly divide. 
Thus, fast-growing tumors are relatively easy to treat with drugs, he said.
The common side effects of chemotherapy-- hair loss, mouth sores and anemia-- 
occur because certain normal tissues are also fast-growing and the drugs kill 
or injure them along with the cancer cells.
But, he added, contrary to a common misconception, cancer chemotherapy 
does not always cause hair loss and nausea and vomiting; many drugs now available 
for cancer cause minimal symptoms.
The idea of using drugs that cause unpleasant side effects is weighed against 
the possibility of successful treatment, he said, saying that "it makes no sense 
to make patients ill if there is no chance of cure."
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ACTIVE CANCERS--
Milder treatment to shrink tumors can maintain a "quality life" for years, 
he said, and often the patient can take the medicine at home.
In some cases older patients "outlive their cancer," he said.
The cancers with which doctors have the most difficulty achieving complete 
remission are, unfortunately, very common in our society, he said. These are 
the cancers of the lung, colon and stomach. The strategy of treatment is often 
to halt the growth of, and not destroy the tumor, he said.
Breast cancer, which afflicts up to one in 13 women during their lifetime, 
has a five-year survival rate of up to 94 percent if the disease is detected as 
early as possible, he said, and a 10-year survival rate of up to 75 percent.
He noted that at the earliest time a tumor can be detected, the number of cancer 
cells is about a billion. Chemotherapy can wipe out only a percentage of those 
cancer cells, he said, and the body’s immune system must take care of the rest.
Next Thursday Dr. Thomas H. Roberts will address the medical implications 
of the nuclear arms race.
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